Adamas to Present at Two Upcoming Investor Conferences
Leerink Partners Global Healthcare Conferenceon Wednesday, February 27at 10:00 a.m. EST( 7:00 a.m. PST) Cowen Health Care Conferenceon Wednesday, March 13at 8:00 a.m. EST( 5:00 a.m. PST)
The presentations will be webcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. Archived versions of the webcasts will be available via replay for 30 days following the presentations.
Adamas’ goal is to create and commercialize a new generation of medicines intended to lessen the burden of chronic neurologic diseases on patients, caregivers and society using its deep understanding of time-dependent biology. The company is focused on the commercial launch of GOCOVRI™ (amantadine) extended release capsules (previously ADS-5102), the first and only
Vice President of Corporate Communications
Source: Adamas Pharmaceuticals, Inc.